Lantern Pharma Inc.

NasdaqCM:LTRN Stock Report

Market Cap: US$38.7m

Lantern Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:LTRN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 May 24SellUS$189,100Bios Equity Partners LPCompany30,000US$6.33

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LTRN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders45,7590.424%
Public Companies631,1955.85%
Private Companies844,1257.83%
VC/PE Firms1,233,80211.4%
Institutions1,248,28011.6%
General Public6,781,56462.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 36.99% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
Bios Equity Partners LP
1,233,802US$4.4m0%3.51%
7.83%
Biological Mimetics, Inc.
844,125US$3.0m-7.66%no data
5.85%
ProPhase Labs, Inc.
631,195US$2.3m0%no data
3.37%
The Vanguard Group, Inc.
363,720US$1.3m0%no data
1.85%
CM Management, LLC
200,000US$717.0k0%0.68%
0.84%
Geode Capital Management, LLC
90,504US$324.5k4.06%no data
0.82%
Renaissance Technologies LLC
88,800US$318.3k1.72%no data
0.56%
NewEdge Advisors, LLC
59,924US$214.8k-12.3%no data
0.46%
Voss Capital, LP
50,000US$179.3k0%0.01%
0.42%
Donald Keyser
45,759US$164.0k9.14%no data
0.37%
BlackRock, Inc.
40,248US$144.3k-0.86%no data
0.37%
Perigon Wealth Management, LLC, Asset Management Arm
39,387US$141.2k170%no data
0.35%
Dimensional Fund Advisors LP
37,483US$134.4k2.56%no data
0.28%
Westside Investment Management, LLC
30,650US$109.9k0%0.02%
0.27%
Horizon Kinetics Holding Corporation
28,791US$103.2k0%no data
0.27%
Sigma Planning Corporation
28,650US$102.7k0.7%no data
0.26%
UBS Asset Management AG
28,091US$100.7k1.47%no data
0.25%
BNY Asset Management
26,482US$94.9k0%no data
0.24%
Davenport Asset Management
25,814US$92.5k0%no data
0.22%
State Street Global Advisors, Inc.
23,652US$84.8k0%no data
0.18%
Incrementum AG
18,888US$67.7k0%0.03%
0.14%
Northern Trust Global Investments
15,589US$55.9k21.7%no data
0.14%
Susquehanna International Group, LLP, Asset Management Arm
14,949US$53.6k-43.2%no data
0.12%
Commonwealth Equity Services, LLC
12,697US$45.5k0%no data
0.093%
Sanctuary Advisors, LLC
10,000US$35.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 18:19
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lantern Pharma Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chad MesserLake Street Capital Markets, LLC
Ashok KumarThinkEquity LLC
John VandermostenZacks Small-Cap Research